-
-
在线客服
-
-
-
-
我的收藏
-
我的订单
-
快速订购
-
-
-
| 产品编号 | CAS号 | 项目名称规格 | 分子式 | 加入购物车 |
|---|---|---|---|---|
| A998477 | Anti-CD19 Reference Antibody (denintuzumab), Anti-CD19 Reference Antibody (denintuzumab), |
|||
| A998478 | Anti-CD19 Reference Antibody (Duke U. patent anti-CD19), Anti-CD19 Reference Antibody (Duke U. patent anti-CD19), |
|||
| A998479 | Anti-CD19 Reference Antibody (Immunomedics hA19), Anti-CD19 Reference Antibody (Immunomedics hA19), |
|||
| A998480 | Anti-CD19 Reference Antibody (inebilizumab), Anti-CD19 Reference Antibody (inebilizumab), |
|||
| A998481 | Anti-CD19 Reference Antibody (obexelimab), Anti-CD19 Reference Antibody (obexelimab), |
|||
| A998482 | Anti-CD19 Reference Antibody (tafasitamab), Anti-CD19 Reference Antibody (tafasitamab), |
|||
| A998483 | Anti-CD2 Reference Antibody (siplizumab), Anti-CD2 Reference Antibody (siplizumab), |
|||
| A666777 | Anti-CD20 & CD3 Reference Antibody (Glofitamab), Target:CD20&CD3,Uniprot:P11836&P07766,Species:Human,isotype:IgG-Fab Anti-CD20 & CD3 Reference Antibody (Glofitamab), Target:CD20&CD3,Uniprot:P11836&P07766,Species:Human,isotype:IgG-Fab |
|||
| A666748 | Anti-CD20 & CD3 Reference Antibody (Odronextamab), Target:CD20&CD3,Uniprot:P11836&P07766,Species:Human,isotype:IgG-like Anti-CD20 & CD3 Reference Antibody (Odronextamab), Target:CD20&CD3,Uniprot:P11836&P07766,Species:Human,isotype:IgG-like |
|||
| A666771 | Anti-CD20 & CD3e Reference Antibody (Mosunetuzumab), Target:CD20&CD3e,Uniprot:P11836&P07766,Species:Human,isotype:IgG-like Anti-CD20 & CD3e Reference Antibody (Mosunetuzumab), Target:CD20&CD3e,Uniprot:P11836&P07766,Species:Human,isotype:IgG-like |
|||
| A666742 | Anti-CD20 & CD47 Reference Antibody (Amulirafusp alfa), Target:CD20&CD47,Uniprot:P11836&P07766,Species:Human,isotype:IgG-FusionProtein Anti-CD20 & CD47 Reference Antibody (Amulirafusp alfa), Target:CD20&CD47,Uniprot:P11836&P07766,Species:Human,isotype:IgG-FusionProtein |
|||
| A998484 | Anti-CD20 Reference Antibody (divozilimab), Anti-CD20 Reference Antibody (divozilimab), |
|||
| A998485 | Anti-CD20 Reference Antibody (ibritumomab), Anti-CD20 Reference Antibody (ibritumomab), |
|||
| A998486 | Anti-CD20 Reference Antibody (obinutuzumab), Anti-CD20 Reference Antibody (obinutuzumab), |
|||
| A998487 | Anti-CD20 Reference Antibody (ocaratuzumab), Anti-CD20 Reference Antibody (ocaratuzumab), |
|||
| A998488 | Anti-CD20 Reference Antibody (ocrelizumab), Anti-CD20 Reference Antibody (ocrelizumab), |
|||
| A998489 | Anti-CD20 Reference Antibody (ofatumumab), Anti-CD20 Reference Antibody (ofatumumab), |
|||
| A998490 | Anti-CD20 Reference Antibody (Regeneron patent anti-CD20), Anti-CD20 Reference Antibody (Regeneron patent anti-CD20), |
|||
| A998491 | Anti-CD20 Reference Antibody (ripertamab), Anti-CD20 Reference Antibody (ripertamab), |
|||
| A998492 | Anti-CD20 Reference Antibody (rituximab), Anti-CD20 Reference Antibody (rituximab), |
